BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang W, Dong W, Li M, Guo Z, Wang Q, Liu Y, Bi Y, Zhou H, Wang Y. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy. ACS Nano 2022;16:3881-94. [PMID: 35238549 DOI: 10.1021/acsnano.1c09048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng Q, Ding B, Ma P, Lin J. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example. Small Methods 2023;:e2201406. [PMID: 36707416 DOI: 10.1002/smtd.202201406] [Reference Citation Analysis]
2 Chen Q, Li C, Wang Q. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death. Small Methods 2023;:e2201457. [PMID: 36703555 DOI: 10.1002/smtd.202201457] [Reference Citation Analysis]
3 Li CY, Anuraga G, Chang CP, Weng TY, Hsu HP, Ta HDK, Su PF, Chiu PH, Yang SJ, Chen FW, Ye PH, Wang CY, Lai MD. Repurposing nitric oxide donating drugs in cancer therapy through immune modulation. J Exp Clin Cancer Res 2023;42:22. [PMID: 36639681 DOI: 10.1186/s13046-022-02590-0] [Reference Citation Analysis]
4 Tatarova Z, Blumberg DC, Bensen A, Mills GB, Jonas O. Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma. Cells 2023;12. [PMID: 36672243 DOI: 10.3390/cells12020308] [Reference Citation Analysis]
5 Huang Y, Suguro R, Hu W, Zheng J, Liu Y, Guan M, Zhou N, Zhang X. Nitric oxide and thyroid carcinoma: A review. Front Endocrinol (Lausanne) 2022;13:1050656. [PMID: 36699047 DOI: 10.3389/fendo.2022.1050656] [Reference Citation Analysis]
6 Chen B, Zhang X, Cheng L, Chen X, Tang J, Zhang P, Wang C, Liu J. Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy. J Control Release 2023;353:889-902. [PMID: 36528194 DOI: 10.1016/j.jconrel.2022.12.030] [Reference Citation Analysis]
7 Ling P, Gao X, Sun X, Yang P, Wang L. Porphyrin-Decorated Cu2O-Encapsulated Metal–Organic Frameworks as pH-Sensitive Biomimetic Catalysts for Mediating Nitric Oxide Production. ACS Appl Nano Mater 2022. [DOI: 10.1021/acsanm.2c04321] [Reference Citation Analysis]
8 Li Y, Yoon B, Dey A, Nguyen VQ, Park JH. Recent progress in nitric oxide-generating nanomedicine for cancer therapy. J Control Release 2022;352:179-98. [PMID: 36228954 DOI: 10.1016/j.jconrel.2022.10.012] [Reference Citation Analysis]
9 Kim T, Nah Y, Kim J, Lee S, Kim WJ. Nitric-Oxide-Modulatory Materials for Biomedical Applications. Acc Chem Res 2022;55:2384-96. [PMID: 35786846 DOI: 10.1021/acs.accounts.2c00159] [Reference Citation Analysis]
10 Lu Z, Bai S, Jiang Y, Wu S, Xu D, Chen Y, Lan Y, An Y, Mao J, Liu X, Liu G. Porphyrin‐Based Covalent Organic Framework for Imaging‐Guided Cancer Combinatorial Immuno‐Sonodynamic Therapy. Adv Funct Materials. [DOI: 10.1002/adfm.202207749] [Reference Citation Analysis]
11 Li Y, Huang J, Yu H, Zhao Y, Xu Z, Kang Y, Xue P. Zirconia-Platinum Nanohybrids for Ultrasound-Activated Sonodynamic-Thermodynamic Bimodal Therapy by Inducing Intense Intracellular Oxidative Stress. Small 2022;:e2203080. [PMID: 35989099 DOI: 10.1002/smll.202203080] [Reference Citation Analysis]